Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Naba Alsaha Medical Services Co EV-to-EBITDA?
Naba Alsaha Medical Services CoSAU:9546 59 EV-to-EBITDA is 14.37 as of Sep. 15, 2026, which is 2% above its 10-year median of 14.09. GuruFocus rates SAU:9546 with a GF Score™ of 59/100 and a GF Value™ of ﷼40.81 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 520 Healthcare Providers & Services companies, Naba Alsaha Medical Services Co ranks worse than 66.15% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Naba Alsaha Medical Services Co's enterprise value is ﷼633.0 Mil.
Naba Alsaha Medical Services Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼44.1 Mil. Therefore, Naba Alsaha Medical Services Co's EV-to-EBITDA for today is 14.37.
The historical rank and industry rank for Naba Alsaha Medical Services Co's EV-to-EBITDA or its related term are showing as below:
SAU:9546'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.48 Med: 14.09 Max: 24.7
Current: 14.37
During the past 5 years, the highest EV-to-EBITDA of Naba Alsaha Medical Services Co was 24.70. The lowest was 8.48. And the median was 14.09.
SAU:9546's EV-to-EBITDA is ranked worse than 66.15% of 520
companies
in the Healthcare Providers & Services industry
Industry Median: 10.33
vs SAU:9546: 14.37
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Naba Alsaha Medical Services Co (SAU:9546) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Naba Alsaha Medical Services Co's PE Ratio (TTM) for today is calculated as:
Naba Alsaha Medical Services Co's share price for today is ﷼24.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Naba Alsaha Medical Services Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼1.360.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co EV-to-EBITDA Chart
SAU:9546 vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Naba Alsaha Medical Services Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naba Alsaha Medical Services Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Naba Alsaha Medical Services Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Naba Alsaha Medical Services Co's EV-to-EBITDA falls into.
Naba Alsaha Medical Services Co's current Enterprise Value is ﷼633.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Naba Alsaha Medical Services Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼44.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co (SAU:9546) has a EV-to-EBITDA of 14.37 as of Sep. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Naba Alsaha Medical Services Co. This is near median its historical median of 14.09. Over the past decade, Naba Alsaha Medical Services Co's EV-to-EBITDA has ranged from 8.48 to 24.70. According to the industry distribution chart, Naba Alsaha Medical Services Co ranks #344 out of 520 companies in the Healthcare Providers & Services industry, placing it in the top 66.2%.
Is Naba Alsaha Medical Services Co's EV-to-EBITDA too high?
Naba Alsaha Medical Services Co's current EV-to-EBITDA of 14.37 is near median its 10-year median of 14.09. Over the past 10 years, this metric has ranged from a low of 8.48 to a high of 24.70. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.33. Naba Alsaha Medical Services Co's value of 14.37 is 39.1% above this industry median. Based on the distribution chart, Naba Alsaha Medical Services Co ranks #344 out of 520 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Naba Alsaha Medical Services Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naba Alsaha Medical Services Co's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Naba Alsaha Medical Services Co ranks #344 out of 520 companies for EV-to-EBITDA. This places Naba Alsaha Medical Services Co in the lower half of its industry. The industry median EV-to-EBITDA is 10.33. Naba Alsaha Medical Services Co's value of 14.37 is 39.1% above this benchmark. Historically, Naba Alsaha Medical Services Co's own EV-to-EBITDA has ranged from 8.48 to 24.70 over the past decade. While the company's 10-year median is 14.09 vs. the industry median of 10.33, Naba Alsaha Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.33, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naba Alsaha Medical Services Co's current EV-to-EBITDA of 14.37 is 39.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Naba Alsaha Medical Services Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naba Alsaha Medical Services Co's current EV-to-EBITDA is 14.37, which is near median its own 10-year median of 14.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naba Alsaha Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co (SAU:9546) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼40.81, compared to a current price of ﷼24.00 — trading 41.2% below its estimated fair value. The current EV-to-EBITDA is 14.37, which is near median its 10-year median of 14.09 and 39.1% above the Healthcare Providers & Services industry median of 10.33. Naba Alsaha Medical Services Co's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Naba Alsaha Medical Services Co (SAU:9546), the current EV-to-EBITDA is 14.37 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naba Alsaha Medical Services Co (SAU:9546) Overvalued in 2026?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co stock appears to be undervalued.
The current stock price of ﷼24.00 is trading 41.2% below its estimated GF Value™ of ﷼40.81.
GuruFocus considers Naba Alsaha Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:9546:
EV-to-EBITDA: 14.37 (near median its 10-year median of 14.09)
GF Value™: ﷼40.81 vs. price of ﷼24.00 (41.2% below fair value)
Industry Position: 39.1% above the Healthcare Providers & Services median (#344 of 520)
No single metric tells the full story. See the SAU:9546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naba Alsaha Medical Services Co is engaged in the medical operation of private and government hospitals, health facilities, and hospital-related activities. It operates and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and the Nabaa Al-Saha branch for the practice of maintenance work and the operation of buildings. Geographically, it operates in the Kingdom of Saudi Arabia.
59GF Score
Get the complete analysis for SAU:9546
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9546 has been successfully added to your 
